News | Cath Lab | May 26, 2022

Abbott Medical Recalls Dragonfly OpStar Imaging Catheter for Potential Loose Catheter Marker Band

The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has identified this as a Class I recall, the most serious type of recall.

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

The Dragonfly OpStar imaging catheter with optical coherence tomography (OCT) imaging system is designed to provide imaging of blood vessels that carry blood and oxygen to the heart (coronary arteries) in people who are candidates for catheter-based, minimally invasive, interventional procedures to address coronary artery disease.

Reason for Recall

Abbott is recalling certain lots of the Dragonfly OpStar imaging catheter because the marker band farthest from the catheter tip (proximal marker) may become loose and, in two instances, has been observed to separate from the catheter while being used on a person.

A loose marker band that has separated from the device may remain in the body after the catheter is removed, potentially leading to vascular injuries, including but not limited to embolism (blockage of the vessel), thrombosis (blood clot), dissection (tear), ischemia (inadequate blood supply to the heart), infarction (heart attack), infection, or death.

There have been 5 incidents and 1 injury related to this device issue. No deaths have been associated with the use of this device due to this issue.

Who May be Affected

  • Health care personnel who use the Dragonfly OpStar Imaging Catheter for OCT imaging of the coronary arteries.
  • People who will have catheter-based OCT imaging of the coronary arteries using the Dragonfly OpStar Imaging Catheter. This issue does not impact people who have already had this procedure.

Recalled Product

  • Product Name: Dragonfly OpStar Imaging Catheter

  • Product Lot Numbers: See recall database entry

  • Devices Recalled in the U.S.: 4,800

  • Date Initiated by Firm: April 11, 2022

What to Do

On April 11, 2022, Abbott issued an Urgent Medical Device Recall letter to all customers who received affected devices. The following instructions were included:

  • Immediately stop using devices from affected lots
  • Review inventory and complete the Effectiveness Check Form Included with the Urgent Medical Device recall letter.
  • Return all unused affected devices to Abbott.
  • Share this information with all relevant personnel.
  • Notify anyone who may have received these affected products through additional distribution or transfer.
  • Report any product performance issues or adverse events to Abbott.

Contact Information

Customers with questions or concerns about this recall should contact their local Abbott representative or call the customer service department at 800-227-9902.

Related Dragonfly OpStar Imaging Catheter information:

FDA Clears Abbott OCT Imaging Enhanced With Artificial Intelligence

Abbott’s New Artificial Intelligence OCT Coronary Imaging Platform Launches in Europe


Related Content

News | Cardiovascular Business

September 21, 2023 — Many of the nation’s most prominent cardiovascular organizations, representing tens of thousands of ...

Home September 21, 2023
Home
News | Cardiovascular Business

September 15, 2023 — The American College of Cardiology (ACC) has recognized five Hackensack Meridian Health hospitals ...

Home September 15, 2023
Home
Feature | Cardiovascular Business | By Emily Gilbert and Kamran Zamanian, PhD

The global interventional cardiology device market is driven by the number of procedures performed across the globe. The ...

Home September 12, 2023
Home
News | Cardiovascular Business

September 11, 2023 — The Heart Rhythm Society (HRS) is gearing up for its second annual HRX event, bringing ...

Home September 11, 2023
Home
News | Cardiovascular Business

September 11, 2023 — Elucid, Inc., a leading medical technology company providing physicians with AI-powered imaging ...

Home September 11, 2023
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

As we wind down the summer months, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.com ...

Home August 31, 2023
Home
Feature | Cardiovascular Business

August 22, 2023 — Leaders at University Hospitals (UH) Harrington Heart & Vascular Institute are saddened to share news ...

Home August 22, 2023
Home
News | Cardiovascular Business

August 17, 2023 — MemorialCare, a prominent nonprofit Southern California integrated health system, announced today that ...

Home August 17, 2023
Home
News | Cardiovascular Business

August 10, 2023 — It is the position of SCAI that ABIM diplomates who successfully pass their exams and report ...

Home August 10, 2023
Home
News | Cardiovascular Business

August 2, 2023 — Dr. Doria Scortichini, MD FACC joins the growing Auburn Heart Institute that is affiliated with Auburn ...

Home August 02, 2023
Home
Subscribe Now